OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $27,679,000 | +3.1% | 2,865,358 | 0.0% | 0.01% | +11.1% |
Q4 2015 | $26,848,000 | -32.8% | 2,865,358 | +0.8% | 0.01% | -35.7% |
Q3 2015 | $39,979,000 | -33.1% | 2,843,480 | 0.0% | 0.01% | -30.0% |
Q2 2015 | $59,798,000 | -31.6% | 2,843,480 | +36.5% | 0.02% | -33.3% |
Q1 2015 | $87,463,000 | +303.8% | 2,083,200 | +126.2% | 0.03% | +328.6% |
Q4 2014 | $21,662,000 | +57.1% | 921,000 | 0.0% | 0.01% | +40.0% |
Q3 2014 | $13,787,000 | – | 921,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
Covestor Ltd | 37,404 | $117 | 0.09% |
GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |